June 20, 2023
An abstract reporting the protocol details of the LIPUS-Heart pivotal trial has been accepted for this year’s CTAD (Clinical Trials on Alzheimer’s Disease, October 24-27, Boston).
The abstract is as follows
Hiroaki Shimokawa, Masanori Akishita, Masafumi Ihara, Satoshi Teramukai, Aiko Ishiki, Yoji Nagai, Hajimu Kato, Masanori Fukushima. Pivotal trial of low-intensity pulsed ultrasound therapy for early stage of Alzheimer’s disease (LIPUS-AD) –Rationale and design-
CTAD is the world’s largest conference on Alzheimer’s disease. https://www.ctad-alzheimer.com/
This year, our presentation has been selected as a “Focus Discussion Poster” and is expected to attract much attention.
Sound Wave Innovation Co., Ltd.